Operating Margin of Lineage Cell Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Lineage Cell Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Lineage Cell Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2025 was -252%, a 11% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2025 was -252%, a 11% decline from 2024.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2024 was -226%, a 18% increase from 2023.
  • Lineage Cell Therapeutics, Inc. annual Operating Margin for 2023 was -276%, a 81% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -252% -25% -11% 01 Oct 2025 31 Dec 2025
Q3 2025 -325% -65% -25% 01 Jul 2025 30 Sep 2025
Q2 2025 -323% +91% +22% 01 Apr 2025 30 Jun 2025
Q1 2025 -223% +86% +28% 01 Jan 2025 31 Mar 2025
Q4 2024 -226% +50% +18% 01 Oct 2024 31 Dec 2024
Q3 2024 -261% +24% +8.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -414% -190% -85% 01 Apr 2024 30 Jun 2024
Q1 2024 -309% -117% -61% 01 Jan 2024 31 Mar 2024
Q4 2023 -276% -123% -81% 01 Oct 2023 31 Dec 2023
Q3 2023 -285% +31% +9.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -224% +122% +35% 01 Apr 2023 30 Jun 2023
Q1 2023 -192% +336% +64% 01 Jan 2023 31 Mar 2023
Q4 2022 -153% +980% +86% 01 Oct 2022 31 Dec 2022
Q3 2022 -316% +445% +58% 01 Jul 2022 30 Sep 2022
Q2 2022 -346% +1116% +76% 01 Apr 2022 30 Jun 2022
Q1 2022 -529% +1002% +65% 01 Jan 2022 31 Mar 2022
Q4 2021 -1134% +315% +22% 01 Oct 2021 31 Dec 2021
Q3 2021 -761% 01 Jul 2021 30 Sep 2021
Q2 2021 -1462% 01 Apr 2021 30 Jun 2021
Q1 2021 -1530% 01 Jan 2021 31 Mar 2021
Q4 2020 -1448% 01 Oct 2020 31 Dec 2020

Lineage Cell Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2025 -252% -25% -11% 01 Jan 2025 31 Dec 2025
2024 -226% +50% +18% 01 Jan 2024 31 Dec 2024
2023 -276% -123% -81% 01 Jan 2023 31 Dec 2023
2022 -153% +980% +86% 01 Jan 2022 31 Dec 2022
2021 -1134% +315% +22% 01 Jan 2021 31 Dec 2021
2020 -1448% 01 Jan 2020 31 Dec 2020
2015 -935% +31% +3.2% 01 Jan 2015 31 Dec 2015
2014 -966% +296% +23% 01 Jan 2014 31 Dec 2014
2013 -1263% -624% -98% 01 Jan 2013 31 Dec 2013
2012 -639% -217% -52% 01 Jan 2012 31 Dec 2012
2011 -421% -156% -59% 01 Jan 2011 31 Dec 2011
2010 -266% 01 Jan 2010 31 Dec 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.